e-learning
resources
Munich 2014
Sunday, 07.09.2014
Mesothelioma: a never-ending story
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them
A. Scherpereel (Lille, France)
Source:
International Congress 2014 – Mesothelioma: a never-ending story
Session:
Mesothelioma: a never-ending story
Session type:
Symposium
Number:
387
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Scherpereel (Lille, France). Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them. International Congress 2014 – Mesothelioma: a never-ending story
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Bernard Yung - 02.11.2014 15:35
Informative thank you.
You must
Login
to comment this presentation.
Related content which might interest you:
Diagnosis and staging of malignant pleural mesothelioma
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Mesothelioma
Related content which might interest you:
Approaches to radiological staging of mesothelioma relating to modern treatment modalities
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
Malignant mesothelioma: new treatment advances, including targeted therapies
Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Year: 2021
From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Combination immunotherapy in mesothelioma: managing expectations and new toxicities
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021
Combined interventional diagnostic modalities
Source: ERS Skills Course 2016
Year: 2016
Regional chemotherapy: a new combined modality approach
Source: Annual Congress 2004 - Lung metastases
Year: 2004
Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Safety and effectiveness of flexible endobronchial cryotherapy as a diagnostic and concurrently therapeutic modality
Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy
Year: 2010
Bronchiectasis: state-of-the-art diagnostic and therapeutic approaches
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014
The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Four-month regimens: are they feasible?
Source: International Congress 2015 – Tuberculosis: short-course chemotherapy
Year: 2015
New molecular-directed therapies for mesothelioma: have there been any advances?
Source: International Congress 2014 – Mesothelioma: a never-ending story
Year: 2014
Combined modality treatment for NSCLC
Source: Annual Congress 2007 - PG7 - Thoracic oncology: nonsmall cell lung cancer
Year: 2007
Screening of lung cancer: imaging modalities
Source: Annual Congress 2009 - PG2 Core Curriculum Postgraduate Course: Lung cancer imaging: case and problem based
Year: 2009
Rationalising combined use of interventional bronchoscopic modalities
Source: School Course 2014 - Interventional Bronchoscopy
Year: 2014
Multimodal imaging approaches in suspected and confirmed lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018
A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept